Table of Content

Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Information Sources
1.5 Methodology
1.6 Geographic Breakdown
1.7 Analyst’s Credentials

Chapter 2 Summary and Highlights

Chapter 3 Market Overview
2.1 Introduction
2.2 Classification of Microarrays Based on Mode of Preparation
2.3 Types of Microarrays Used in Different Probes
2.4 DNA Microarrays
2.4.1 How a DNA Microarray Works
2.4.2 DNA Microarray Types
2.4.3 DNA Microarray Applications
2.4.4 SNP Analysis
2.4.5 Epigenetic Analysis
2.4.6 Cytogenetic Analysis
2.4.7 Micro-RNA Analysis
2.4.8 Bead-Based Arrays
2.4.9 Catalog and Custom DNA Microarrays
2.5 Protein Microarray Technologies
2.5.1 Introduction
2.5.2 Proteomics Workflow
2.5.3 Protein Microarray Design
2.5.4 Applications of Protein Microarrays
2.5.5 Types of Protein Microarrays
2.5.6 Challenges of Protein Microarray Technologies
2.5.7 Emerging Microarray Technologies

Chapter 4 Impact of COVID-19 Pandemic
4.1 Impact of COVID-19 on the Microarray Technologies Market
4.1.1 Invention of a Microarray for Coronavirus Antigen
4.1.2 Determination of SARS-CoV-2 Convalescent Blood Specimens Using CoVAM
4.1.3 Methods for Testing COVID-19
4.1.4 SARS-CoV-2 Research Products

Chapter 5 Global Microarray Market by Product Type
5.1 Overview
5.2 DNA Microarrays
5.3 Protein Microarrays
5.4 Other Microarrays
5.4.1 Market Drivers
5.4.2 Challenges

Chapter 6 Global Microarray Market
6.1 Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World

Chapter 7 Global Microarray Market by Application
7.1 Introduction
7.1.1 Challenges in Drug Development
7.1.2 Drug Discovery and Development Process
7.1.3 Identification of Drug Target
7.1.4 Drug Discovery
7.2 Diagnostics Applications
7.2.1 Diagnostics Tools Differ from Research Tools
7.2.2 Drivers
7.3 Clinical Diagnostic Indications
7.4 Cancer Clinical Diagnostics
7.4.1 Lung Cancer
7.4.2 Breast Cancer
7.4.3 Colorectal Cancer
7.4.4 Pan-Cancer
7.4.5 Other Cancers
7.4.6 Oncology Screening/Early Detection
7.4.7 Oncology Diagnosis
7.4.8 Oncology Therapy Guidance
7.4.9 Oncology Monitoring

Chapter 8 Company Profiles
ABBOTT LABORATORIES
ABBVIE INC.
ADVANCED CELL DIAGNOSTICS INC.
AGILENT TECHNOLOGIES
ARTIVION INC.
BECTON, DICKINSON AND CO.
BENITEC BIOPHARMA LTD.
CALADRIUS BIOSCIENCES
CELGENE CORP.
COMMENCE BIO
DEPUY SYNTHES (J&J)
DR?GERWERK AG & CO. KGAA
EPIC SCIENCES INC.
GENEXINE
GERON
ILLUMINA INC.
IMMUNOCELLULAR THERAPEUTICS
INEX INNOVATIONS EXCHANGE PTE. LTD.
INIVATA LTD.
INTERPACE DIAGNOSTICS LLC.
INVIVOSCRIBE INC.
MEDTRONIC PLC
MERCK KGAA
NOVARTIS AG
ONCOCYTE CORP.
ONCOMED PHARMACEUTICALS INC.
PLURISTEM THERAPEUTICS INC.
SILICON BIOSYSTEMS S.P.A
SPHERE FLUIDICS LTD.
THERMO FISHER SCIENTIFIC
VITATEX INC.

Chapter 9 Patent Reviews



List of Figures


Summary Figure : Global Market for Microarrays, by Segment, 2021-2027
Figure 1 : Shares of Global Market for Microarrays, by Segment, 2027
Figure 2 : Global Market for DNA Microarrays, 2019-2027
Figure 3 : Global Market for Protein Microarrays, 2019-2027
Figure 4 : Global Market for Other Microarrays, 2019-2027
Figure 5 : Shares of Global Market for Microarrays, by Region, 2027
Figure 6 : Shares of North American Market for Microarrays, by Country, 2027
Figure 7 : Shares of European Market for Microarrays, by Country, 2027
Figure 8 : Shares of Asia-Pacific Market for Microarrays, by Country, 2027
Figure 9 : Global Market for Microarrays, by Application, 2019-2027
Figure 10 : Drug Discovery and Development Timeline
Figure 11 : Becton, Dickinson and Co.: Revenue, by Business Segment, 2021
Figure 12 : Illumina Inc.: Annual Revenue, 2018-2021
Figure 13 : Illumina Inc.: Revenue Share, by Region/Country, 2021
Figure 14 : Illumina Inc.: Revenue Share, by Segment, 2021

List of Tables


Summary Table : Global Market for Microarrays, by Segment, Through 2027
Table 1 : Comparison of DNA and Protein Microarrays
Table 2 : Microarray Genome Content
Table 3 : DNA Microarray Platform Features
Table 4 : Applications of DNA Microarrays
Table 5 : Comparison of Genetic Analysis Technologies
Table 6 : SNP Measurement Platforms
Table 7 : Comparison of Chromosomal Change Detection Technologies
Table 8 : Workflow for a Micro-RNA Experiment
Table 9 : Comparison of Bead–Based Arrays and Planar Microarrays
Table 10 : Protein Microarrays
Table 11 : Protein Microarrays as Research Tools
Table 12 : Types of Protein Microarrays
Table 13 : Challenges of Protein Microarrays
Table 14 : Emerging Technologies of Microarray Technologies
Table 15 : Number of COVID-19 Confirmed Cases and Deaths Globally, by Region, as of June, 2022
Table 16 : COVID-19 Confirmed Cases and Deaths Globally, by Country, as of June 20, 2022
Table 17 : Global Microarray Market, by Segment, Through 2027
Table 18 : Microarray on Major Biochip Types
Table 19 : Global DNA Microarray Market, by Product, Through 2027
Table 20 : Comparison of Microarrays
Table 21 : Global Protein Microarray Market, by Product, Through 2027
Table 22 : Competing Platforms, by Multiplexing Density
Table 23 : Global Market for Other Microarrays, Through 2027
Table 24 : Global Microarray Market, by Region, Through 2027
Table 25 : North American Market for Microarrays, by Country, Through 2027
Table 26 : European Market for Microarrays, by Country, Through 2027
Table 27 : Asia-Pacific Market for Microarrays, by Country, Through 2027
Table 28 : RoW Market for Microarrays, Through 2027
Table 29 : Microarray Life Sciences Applications
Table 30 : Global Market for Microarrays, by Application, Through 2027
Table 31 : Biochip Applications in Drug Discovery and Development
Table 32 : Keys Needs in Drug Discovery and Development
Table 33 : Requirements for an Epigenetics Bisulphate Diagnostic Test
Table 34 : Biomarkers Used in Microarray Diagnostics
Table 35 : Clinical Diagnostics by Indication
Table 36 : Limitations of Tissue Biopsy in Cancer Applications
Table 37 : NIH Liquid Biopsy Early Detection Initiative
Table 38 : Clinical Trials on Lung Cancer Liquid Biopsies
Table 39 : Five-Year Survival Rates for Ovarian Cancer
Table 40 : MRI and Liquid Biopsy Methods
Table 41 : Early Detection Tissue of Origin Approaches
Table 42 : Abbott Laboratories: Product Portfolio
Table 43 : Abbott Laboratories: Developments 2020-2022
Table 44 : Abbvie: Oncology Pharmaceutical Products Portfolio
Table 45 : Abbvie: Marketed Products
Table 46 : Abbvie: Key Developments
Table 47 : Allergan Plc: Marketed Products
Table 48 : Advanced Cell Diagnostics: Product Portfolio
Table 49 : Agilent: Developments, 2019-2022
Table 50 : Artivion Inc.: Product Portfolio
Table 51 : Artivion Inc.: Developments, 2020
Table 52 : Becton, Dickinson and Co.: Company Financials, 2021
Table 53 : Becton, Dickinson and Co.: Product Portfolio
Table 54 : Becton, Dickinson and Co.: Developments, 2017-2022
Table 55 : Benitec Biopharma: Product Portfolio
Table 56 : Caladrius Biosciences: Product Portfolio
Table 57 : Celgene Corp.: Product Portfolio
Table 58 : Commence Bio: Product Portfolio
Table 59 : DePuy Synthes: Product Portfolio
Table 60 : DePuy Synthes: Developments, 2019-2022
Table 61 : Dr?ger: Product Portfolio
Table 62 : Epic Sciences: Product Portfolio
Table 63 : Genexine: Product Portfolio
Table 64 : Geron: Product Portfolio
Table 65 : ImmunoCellular Therapeutics: Product Portfolio
Table 66 : Medtronic plc: Developments, 2019-2022
Table 67 : Novartis: Developments, 2019 and 2020
Table 68 : OncoCyte: Product Portfolio
Table 69 : OncoMed: Product Portfolio
Table 70 : Pluristem Therapeutics: Product Portfolio
Table 71 : Silicon Biosystems: Product Portfolio
Table 72 : Sphere Fluidics: Product Portfolio
Table 73 : Thermo Fisher Scientific: Product Portfolio
Table 74 : Thermo Fisher Scientific: Developments, 2019-2022
Table 75 : Vitatex: Product Portfolio
Table 76 : Microarray Technology Patents 2021 and 2022